Your browser doesn't support javascript.
loading
Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group.
Patrikidou, Anna; Domont, Julien; Chabaud, Sylvie; Ray-Coquard, Isabelle; Coindre, Jean-Michel; Bui-Nguyen, Binh; Adenis, Antoine; Rios, Maria; Bertucci, François; Duffaud, Florence; Chevreau, Christine; Cupissol, Didier; Pérol, David; Emile, Jean-François; Blay, Jean-Yves; Le Cesne, Axel.
Afiliação
  • Patrikidou A; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
  • Domont J; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
  • Chabaud S; Biostatistics Department, Centre Léon Bérard, Lyon, France.
  • Ray-Coquard I; Biostatistics Department, Centre Léon Bérard, Lyon, France.
  • Coindre JM; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Bui-Nguyen B; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Adenis A; Department of Medical Oncology, Centre Oscar Lambret, Lille, France.
  • Rios M; Department of Medical Oncology, Centre Alexis Vautrin, Nancy, France.
  • Bertucci F; Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France.
  • Duffaud F; Department of Medicine, Hopital La Timone, Marseille, France.
  • Chevreau C; Department of Medicine, Institut Claudius Regaud, Toulouse, France.
  • Cupissol D; Department of Medical Oncology, Institut du Cancer du Montpellier, Montpellier, France.
  • Pérol D; Biostatistics Department, Centre Léon Bérard, Lyon, France.
  • Emile JF; Université de Versailles and Hôpital Ambroise Paré, Boulogne, France.
  • Blay JY; CRCL INSERM U1052 & Université Claude Bernard Lyon 1 & Centre Léon Bérard, Lyon, France.
  • Le Cesne A; Department of Cancer Medicine, Gustave Roussy, Villejuif, France. Electronic address: Axel.LECESNE@gustaveroussy.fr.
Eur J Cancer ; 52: 173-80, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26687836

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Proteínas Proto-Oncogênicas c-kit / Tumores do Estroma Gastrointestinal / Inibidores de Proteínas Quinases / Mesilato de Imatinib / Neoplasias Gastrointestinais / Mutação / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Proteínas Proto-Oncogênicas c-kit / Tumores do Estroma Gastrointestinal / Inibidores de Proteínas Quinases / Mesilato de Imatinib / Neoplasias Gastrointestinais / Mutação / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido